全球唯一心房顫動血壓計--百略醫學microlife-專業技術

心房顫動偵測專利技術 (AFIB)

百略醫學的AFIB專利技術可以在血壓測量過程
中偵測心房顫動，做為提早就醫咨詢的方法

心房顫動 AFIB

心房顫動是最致命的一種心律不整現象

百略醫學的AFIB心房顫動偵測專利技術能有效篩檢出最危險致命的心律不整 -心房顫動，排除其他因生理與人為因素造成的心律不整。經由百略醫學的專利技術可以在血壓測量過程中自動偵測心房顫動，使用者在MAM三次平均模式下進行測量，如發現心房顫動，屏幕會顯示圖標，做為及早就醫確診與醫療咨詢的方法，幫助病患瞭解自身健康狀況。

準確專注篩檢心房顫動

臨床證實Microlife的心房顫動偵測具有高度敏感性(98%)與高度特異性(92%)

靈敏度

98%

臨床研究累計超過 10,000 名樣本，並發表於國際知名期刊。

特異性

92%

經臨床實證，在基層醫療/居家量測血壓，同時偵測心房顫動，可作為 AF 初篩的可靠工具。

獲英國國家健康與照顧卓越研究院NICE官方正式推薦

醫師專業推薦： No.1 的心房顫動偵測技術！

Microlife 的心房顫動偵測技術，已經臨床實驗證明瞭準確度，研究也顯示在第一線臨床使用，有助於篩檢出新的AFIB個案。「建議使用於可能罹患高血壓的高危險群＆高血壓族群的血壓管理。」

國際臨床實證列表

	Patients (n)	Setting	Average age (y)	AF n (%)	Non-AF arrhythmia (n)	Sinus (n)	Sensitivity (%)	Specificity (%)
Wiesel 2004	450	Hospital	69	53	(12) 1	396	100	92
Stergiou 2009	73	Hospital	71	27	(37) 23	23	100	89
Wiesel 2009	405	Hospital	73	93	(23) 64	248	97	89
Wiesel 2013 (Tripps)	139	Home	67	14 (10)		125	99*	93*
Oxford trial 2014	999	Primary care	80	79 (8	n.s.	920	95	90
Wiesel 2014	183	Hospital	74	30 (15)	n.s	153	100	92
Gandolfo 2015	207	Hospital	78	38 (18.4)	n.s.	169	90	99

2013 Oxford Trail牛津臨床試驗

著名的英國牛津大學在2013年，針對1,000名家醫科患者進行了一項隨機臨床試驗，研究結果表明:

百略醫學的AFIB對於心房顫動的初步篩檢來說是最好的選擇，量血壓同時量測，操作簡單不需專業解釋，且準確度可媲美診間使用的單導ECG。

「所以在基層醫療與居家使用上，Microlife AFIB比ECG更適合做為房顫的篩檢工具。這些資料建議使用心房顫動技術進行居家血壓量測，有優異的診斷準確度，因此於初期診斷時可用來作為可靠的篩檢試驗。」- Dr. George S. Stergiou（（ESH成員，歐洲著名高血壓專家，已發表5本著作＆超過１５０篇相關研究）

國內外參考文獻

Nichols M TN, Luengo-Fernandez R, Leal J, Gray A, Scarborough P, Rayner M European Cardiovascular Disease Statistics 2012. European Heart Network, Brussels, European Society of Cardiology, Sophia Antipolis 2012.
Boriani G, Laroche C, Diemberger I, Fantecchi E, Popescu MI, Rasmussen LH et al.: Asymptomatic atrial fibrillation: clinical correlates, management, and outcomes in the EORP-AF Pilot General Registry. Am J Med 2015; 128:509-518 e502.
Zoni-Berisso M, Lercari F, Carazza T, Domenicucci S: Epidemiology of atrial fibrillation: European perspective. Clin Epidemiol 2014; 6:213-220.
Sanna T, Diener HC, Passman RS, Di Lazzaro V, Bernstein RA, Morillo CA et al.: Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med 2014; 370:2478-2486.
Gladstone DJ, Spring M, Dorian P, Panzov V, Thorpe KE, Hall J et al.: Atrial fibrillation in patients with cryptogenic stroke. N Engl J Med 2014; 370:2467-2477.
Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH et al.: 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation–developed with the special contribution of the European Heart Rhythm Association. Europace 2012; 14:1385-1413.
Hart RG, Benavente O, McBride R, Pearce LA: Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med 1999; 131:492-501.
Ruff CT, Giugliano RP, Braunwald E, Hoffman EB, Deenadayalu N, Ezekowitz MD et al.: Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet 2014; 383:955-962.
Verberk WJ, Omboni S, Kollias A, Stergiou GS: Screening for atrial fibrillation with automated blood pressure measurement: Research evidence and practice recommendations. Int J Cardiol 2016; 203:465-473.
Wiesel J, Wiesel D, Suri R, Messineo FC: The use of a modified sphygmomanometer to detect atrial fibrillation in outpatients. Pacing Clin Electrophysiol 2004; 27:639-643.

Wiesel J, Wiesel D, Suri R, Messineo FC: The use of a modified sphygmomanometer to detect atrial fibrillation in outpatients. Pacing Clin Electrophysiol 2004; 27:639-643.
Stergiou GS, Karpettas N, Protogerou A, Nasothimiou EG, Kyriakidis M: Diagnostic accuracy of a home blood pressure monitor to detect atrial fibrillation. J Hum Hypertens 2009; 23:654-658.
Wiesel J, Fitzig L, Herschman Y, Messineo FC: Detection of atrial fibrillation using a modified microlife blood pressure monitor. Am J Hypertens 2009; 22:848-852.
Wiesel J, Abraham S, Messineo FC: Screening for asymptomatic atrial fibrillation while monitoring the blood pressure at home: trial of regular versus irregular pulse for prevention of stroke (TRIPPS 2.0). Am J Cardiol 2013; 111:1598-1601.
Kearley K, Selwood M, Van den Bruel A, Thompson M, Mant D, Hobbs FR et al.: Triage tests for identifying atrial fibrillation in primary care: a diagnostic accuracy study comparing single-lead ECG and modified BP monitors. BMJ Open 2014; 4:e004565.
Wiesel J, Arbesfeld B, Schechter D: Comparison of the Microlife blood pressure monitor with the Omron blood pressure monitor for detecting atrial fibrillation. Am J Cardiol 2014; 114:1046-1048.
Gandolfo C, Balestrino M, Bruno C, Finocchi C, Reale N: Validation of a simple method for atrial fibrillation screening in patients with stroke. Neurol Sci 2015; 36:1675-1678.
Chan PH, Wong CK, Pun L, Wong YF, Wong MM, Chu DW et al.: Head-to-Head Comparison of the AliveCor Heart Monitor and Microlife WatchBP Office AFIB for Atrial Fibrillation Screening in a Primary Care Setting. Circulation 2017; 135:110-112.
Chan PH, Wong CK, Pun L, Wong YF, Wong MM, Chu DW et al.: Diagnostic performance of an automatic blood pressure measurement device, Microlife WatchBP Home A, for atrial fibrillation screening in a real-world primary care setting. BMJ Open 2017; 7:e013685.
Alpert BS, Quinn D, Gallick D: Oscillometric blood pressure: a review for clinicians. J Am Soc Hypertens 2014; 8:930-938.
NICE: WatchBP Home A for opportunistically detecting atrial fibrillation during diagnosis and monitoring of hypertension http://guidance.nice.org.uk/MTG13. 2013; Assessed 18 Aug. 2015.